Abcuro

1 follower

‌

Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class ant... Read more

Industries

Headquarters

Newton, United States

Employees

Links

Org chart

Chief Executive Officer

Alex Martin

Collapse

COO

H. Jeffrey Wilkins, MD

Chief Medical Officer

Ricky Motschwiller

Vice President Finance

Dulce Soler-Ferran

VP, Biology

Janaki Subramanyam

VP, Head of Regulatory Affairs

Research VP, Head of Data Management

VP, Clinical Science

VP, Clinical Development & Head, Clinical Trial Management

Head, Corporate Development

Senior Director, Program Management

Senior Director, Operations

Hugo Lemessurier

Director

Director, Clinical Operations

Director, CMC Manufacturing Operations

Associate Director, GMP QA Operations

VP, Information Technology

Director, Analytical Development

Director, GMP Quality Drug Substance

Director & Head, Manufacturing

Director, Human Resources

Director, Quality Control

Director, Quality Systems

Senior Manager, CMC Downstream Manufacturing

Senior Manager, Regulatory Affairs

Stephanie Amador

Senior Manager, CMC Project Management

Teams

Management and Directors

11 members

Leadership Team

5 members

Quality and Regulatory Team

7 members

Supply Chain and Manufacturing

7 members

Clinical Operations Team

5 members

Finance and Accounting Team

5 members

Similar companies

Thermo Fisher Scientific

164 followers

Gilead Sciences

128 followers

Biogen

114 followers

BeiGene

20 followers

Kura Oncology

17 followers

Lantern Pharma

24 followers

Natera

13 followers

Charles River Laboratories

11 followers

Beam

7 followers

ARS Pharmaceuticals

1 follower

Foundation Medicine

5 followers

Explore companies